Open AccessEfficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer
Author(s) -
O. Karginova,
M. B. Siegel,
A. E. D. Van Swearingen,
A. M. Deal,
B. Adamo,
M. J. Sambade,
S. Bazyar,
N. Nikolaishvili-Feinberg,
R. Bash,
S. O'Neal,
K. Sandison,
J. S. Parker,
C. Santos,
D. Darr,
W. Zamboni,
Y. Z. Lee,
C. R. Miller,
C. K. Anders
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/jy3y-pj77
Subject(s) - triple negative breast cancer , carboplatin , breast cancer , brca mutation , oncology , triple negative , medicine , cancer research , cancer , chemotherapy , cisplatin